Smith & Nephew plc
Smith & Nephew plc (SNN) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
snn · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Smith & Nephew plc (SNN) measures how much investors pay for each dollar of the company's trailing earnings. SNN's current PE ratio of 20.63x is calculated by dividing its stock price of $30.34 by its TTM earnings per share of $0.74. −32.6% discount vs 5Y avg 30.6x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 20 fiscal years · Front-end computedMinQ1 · 25%23.0x
MedianQ3 · 75%52.8x
Max
At 20.63x, SNN's current P/E is within its average historical range over the past 20 fiscal years.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Smith & Nephew plcYou SNN | $12.9B | 20.63x | -27.2% | $0.74 |
 Centene Corporation CNC | $32.1B | N/A | — | -$13.59 |
 The Cooper Companies, Inc. COO | $13.0B | 37.30x | +31.5% | $1.87 |
 Fresenius Medical Care AG & Co. KGaA FMS | $11.7B | 12.07x | -57.4% | $1.68 |
 Hologic, Inc. HOLX | $17.0B | 26.99x | -4.8% | $2.49 |
 Medpace Holdings, Inc. MEDP | $13.1B | 35.91x | +26.7% | $15.64 |
 Neurocrine Biosciences, Inc. NBIX | $16.4B | 29.49x | +4.0% | $4.81 |
Industry Average 5 peers with valid PE | — | 28.35x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 22.70x | $1.45 | -13.2% | |
2024-12-31 FY2024 | 26.15x | $0.94 | +15.8% | |
2023-12-31 FY2023 | 22.59x | $1.21 | -57.2% | |
2022-12-31 FY2022 | 52.76x | $0.51 | +82.1% | |
2021-12-31 FY2021 | 28.97x | $1.19 | -29.7% | |
2020-12-31 FY2020 | 41.19x | $1.02 | +17.5% | |
2019-12-31 FY2019 | 35.06x | $1.37 | +42.1% | |
2018-12-31 FY2018 | 24.67x | $1.52 | +23.9% | |
2017-12-31 FY2017 | 19.91x | $1.75 | +16.6% | |
2016-12-31 FY2016 | 17.07x | $1.76 | -55.1% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Smith & Nephew plc (SNN) measures how much investors pay for each dollar of the company's trailing earnings. SNN's current PE ratio of 20.63x is calculated by dividing its stock price of $30.34 by its TTM earnings per share of $0.74.
Frequently asked questions
SNN pe ratio · 6 questionsSNN's current PE ratio is 20.63x as of 2026-06-08, based on a stock price of $30.34 and TTM EPS of $0.74. Data sourced from Financial Modeling Prep via SNN's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Smith & Nephew plc SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08